2'3'-cGAMP (sodium salt): STING Agonist for Precision Immunotherapy

Executive Summary: 2'3'-cGAMP (sodium salt) is a cyclic dinucleotide second messenger synthesized by cGAS upon cytosolic DNA detection. It directly binds and activates STING (Kd = 3.79 nM), triggering downstream TBK1/IRF3 signaling and robust type I interferon (IFN-β) production (Zhang et al., 2025). This molecule exhibits superior STING activation compared to other CDNs, making it a critical probe for innate immune pathway interrogation. It has proven essential in studies of tumor vasculature normalization, CD8+ T cell infiltration, and cancer immunotherapy (ApexBio B8362). 2'3'-cGAMP is highly water-soluble (≥7.56 mg/mL) and must be stored at -20°C for stability. Its specificity makes it the benchmark tool in STING research and translational immunology.

Biological Rationale

2'3'-cGAMP (sodium salt) is the endogenous ligand for the stimulator of interferon genes (STING) protein, a key regulator of the innate immune response to cytosolic DNA (Zhang et al., 2025). Synthesized by cGAS, it acts as a second messenger, signaling the presence of pathogenic DNA. The STING pathway links DNA sensing to type I interferon induction, bridging innate and adaptive immunity. Activation of STING leads to phosphorylation of TBK1 and IRF3, culminating in the production of IFN-β and other cytokines. This response is essential for antiviral defense, tumor immunosurveillance, and the shaping of the tumor microenvironment. Notably, STING agonists, like 2'3'-cGAMP, have shown efficacy in normalizing tumor vasculature and enhancing CD8+ T cell infiltration, both critical for effective immunotherapy (see also; this article expands by detailing specific cell-type targeting and clinical translation).

Mechanism of Action of 2'3'-cGAMP (sodium salt)

2'3'-cGAMP (sodium salt) functions by directly binding to the CDN binding domain of STING, a transmembrane protein located in the endoplasmic reticulum. Upon ligand recognition, STING undergoes a conformational change and translocates to the Golgi apparatus. Here, it recruits and activates TANK-binding kinase 1 (TBK1), which phosphorylates interferon regulatory factor 3 (IRF3). Phosphorylated IRF3 dimerizes and translocates to the nucleus, where it drives the transcription of type I interferon genes, especially IFN-β (Zhang et al., 2025).

2'3'-cGAMP binds STING with high affinity (Kd = 3.79 nM, as measured by isothermal titration calorimetry at 25°C in Tris buffer), outperforming other cyclic dinucleotides such as 3'3'-cGAMP or c-di-GMP. This high-affinity interaction ensures robust activation of downstream signaling. STING activation also promotes palmitoylation at cysteine residues (Cys91), facilitating STING clustering and sustained signal transduction. In endothelial cells, 2'3'-cGAMP-mediated STING activation induces JAK1-STAT signaling, further amplifying IFN-I responses and immune cell recruitment (Zhang et al., 2025; related; this article clarifies molecular specificity and translational context).

Evidence & Benchmarks

• 2'3'-cGAMP (sodium salt) binds human STING with a dissociation constant (Kd) of 3.79 nM at 25°C (Zhang et al., DOI).
• STING agonist treatment leads to significant normalization of tumor vasculature and increased infiltration of CD8+ T cells in murine tumor models (DOI).
• 2'3'-cGAMP-induced STING activation requires palmitoylation at Cys91 but not the C-terminal tail domain for JAK1-STAT1 signaling in endothelial cells (DOI).
• In vitro, 2'3'-cGAMP (sodium salt) is soluble at ≥7.56 mg/mL in water, but insoluble in ethanol or DMSO (ApexBio B8362, product sheet).
• Storage at -20°C preserves the chemical and biological stability of 2'3'-cGAMP (sodium salt) for up to 12 months (ApexBio B8362, product sheet).

Applications, Limits & Misconceptions

2'3'-cGAMP (sodium salt) is extensively utilized to dissect cGAS-STING pathway dynamics in innate immunity, cancer biology, and antiviral research. Its high specificity enables cell-type–resolved studies, particularly in endothelial and immune cell contexts (see also; this article updates with new in vivo benchmarks and workflow guidance). In translational settings, it is used to screen STING-targeted therapeutics, understand immune microenvironments, and develop combination immunotherapies.

However, its efficacy may be limited by tumor microenvironmental factors such as immune suppressive cell populations or altered vasculature. Some clinical studies using next-generation STING agonists have shown limited immune infiltration or therapeutic responses in patients with advanced solid tumors, highlighting the importance of delivery route, dosing, and microenvironmental context (Zhang et al., 2025).

Common Pitfalls or Misconceptions

• Misconception: STING agonists induce IFN responses in all cell types equally.
  Clarification: 2'3'-cGAMP (sodium salt) shows cell-type–specific STING activation, with endothelial and dendritic cells being primary responders (DOI).
• Pitfall: Using DMSO or ethanol as a solvent.
  Clarification: The compound is insoluble in DMSO and ethanol; only water or compatible aqueous buffers are recommended (ApexBio).
• Misconception: Higher doses always yield stronger immune activation.
  Clarification: Excessive dosing can cause non-specific toxicity or chronic inflammation (DOI).
• Pitfall: Assuming long-term room temperature storage is acceptable.
  Clarification: Stability is best maintained at -20°C (ApexBio).
• Misconception: All STING agonists are equally effective in clinical settings.
  Clarification: Tumor microenvironment and delivery method critically impact efficacy (DOI).

Workflow Integration & Parameters

For laboratory use, 2'3'-cGAMP (sodium salt) is supplied as a solid, with a molecular weight of 718.37 g/mol and chemical formula C20H22N10Na2O13P2. Dissolve in sterile water to a concentration of at least 7.56 mg/mL. Avoid organic solvents. For in vitro assays, typical working concentrations range from 0.01–10 μM, depending on cell type and assay duration. For in vivo studies, dosing protocols should be titrated based on animal model, route (e.g., intratumoral vs. systemic), and desired pharmacodynamic endpoints (ApexBio B8362).

Store all stock solutions at -20°C, protected from light and repeated freeze-thaw cycles. For optimal results, use within 12 months of receipt. Established protocols include transfection of immune cells, direct administration to tumor-bearing models, and combinatorial screening with checkpoint inhibitors or other immunomodulators (see also; this article clarifies batch selection and storage for reproducibility).

Conclusion & Outlook

2'3'-cGAMP (sodium salt) has established itself as the gold standard STING agonist for both basic and translational research into innate immunity, tumor microenvironment modulation, and immunotherapy development. Its high selectivity, potency, and well-characterized mechanism make it invaluable for dissecting the cGAS-STING pathway, understanding type I interferon induction, and benchmarking new therapeutic strategies. Ongoing studies are expanding its utility in precision immunotherapy and antiviral research, with a focus on cell-type–resolved applications and combinatorial regimens. For detailed protocols and ordering, see the 2'3'-cGAMP (sodium salt) product page.